GYNAZOLE.1 DIN 02248417
Health Canada record
| Active ingredient(s) | BUTOCONAZOLE NITRATE 2 % |
|---|---|
| Dosage form | Cream |
| Route | Vaginal |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | G01AF15 BUTOCONAZOLE |
| Original market date | 20-Apr-2004 |
| Current status date | 15-Jan-2014 |
| Source | Health Canada DPD |
Establishment licence of the holder
Ferring Inc. — licence 100274, currently licensed, last inspection rating C (2026-05-19).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 120 | 2003-12-23 | New Drug Submission (NDS) |
International API supply for BUTOCONAZOLE NITRATE
1 active FDA Drug Master Files.
Request a quote for GYNAZOLE.1